title: [Treatment of patients with resistant urogenital infection].
abstract: In our trial 43 patients with urogenital infections resistant to standard therapy received the same basic therapy (4 tablets of safocid a day for 5 days) which, on demand, was combined with pathogenetic and symptomatic treatment. The effect was achieved by both subjective and objective parameters: pathogenic microflora was not detected after 10 days in 39 (90.7%) patients; none of the patients discharged protozoa, fungi. Tests for chlamidia were negative in all the carriers in 2 months, for ureaplasma--in 94.1% males and 83.3% females, respectively. A significant response was observed in 38 of 43 (88.4%) patients, improvement was seen in 5 (11.6%) patients. The above results persisted for 2 months of follow-up.
authors.forename: E V
authors.initials: EV
authors.lastname: Kul'chavenia
authors.forename: A A
authors.initials: AA
authors.lastname: Breusov
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D005260:Female; D052776:Female Urogenital Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000469:parasitology; D006801:Humans; D008297:Male; D052801:Male Urogenital Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000469:parasitology; D008875:Middle Aged; D012749:Sexually Transmitted Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000469:parasitology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents